GLP1R and myocardial infarction: The risk of acute myocardial infarction (AMI) was reduced by 3.6 % in the GLP-1 RAs group (15.0 % vs. 18.6 %; HR 0.87; 95 % CI: 0.82–0.92; p < 0.001).